Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Gastroenterology|December 1, 2005
Therapeutic efficacy of infliximab on active Crohn's disease under nutritional therapyTakayuki Matsumoto, Mitsuo Iida, Yutaka Kohgo, et al.
International Journal of Clinical Oncology|October 31, 2003
Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapyHiroaki Iwase, Masaaki Shimada, Motonori Nakamura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Intestinal fibroblast-derived IL-10 increases survival of mucosal T cells by inhibiting growth factor deprivation- and Fas-mediated apoptosisKenji Ina, Kazuo Kusugami, Yasushi Kawano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 3, 2002
[A pilot study of TS-1 combined with cisplatin in patients with advanced gastric cancer]Hiroaki Iwase, Masaaki Shimada, Motosuke Nakamura, et al.
Journal of Gastroenterology and Hepatology|April 19, 2003
Enhanced somatostatin secretion into the gastric juice with recovery of basal acid output after Helicobacter pylori eradication in gastric ulcersToshihiko Hayakawa, Hiroshi Kaneko, Toshihiro Konagaya, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 31, 2002
[Complete response in a case of advanced scirrhous type 3 gastric cancer of with bulky N2 para-aorta lymph node metastases treated by combined chemotherapy of TS-1 and CDDP]Hiroaki Iwase, Masaaki Shimada, Motosuke Nakamura, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
Effect of glycine on Helicobacter pylori in vitroMasaaki Minami, Takafumi Ando, Shin-Nosuke Hashikawa, et al.
World Journal of Gastroenterology|January 19, 2006
Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonizationTomokazu Mizuno, Takafumi Ando, Kazuo Nobata, et al.
Pageof 3